Distribution
Quotation, order processing and fulfillment for both product lines, with reference numbers and case quantities formatted for your purchasing system.
About Hemovance
A medical sales team built around one product line
Hemovance is a growing medical sales representative company and the United States distributor of WoundClot® Hemostatic Gauze. We supply, support and provide clinical education for one product category — advanced bleeding control — across the lower 48 states.
48
Contiguous states served
1
Product line represented
2
Care settings: acute and prehospital
4
Areas of account responsibility
01 — Who we are
A single-line specialist organization
Hemovance represents one technology. Every member of the team is trained on the mechanism of action, the cleared indications, the available configurations, and the clinical settings in which WoundClot® is — and is not — appropriate.
That focus is deliberate. A hemostatic dressing is selected by clinicians who must justify the decision to a value analysis committee and then rely on the product during active hemorrhage. Those discussions require a representative able to address a trauma surgeon, a perioperative director and a materials manager with equal competence.
Hemovance is a growing organization. Our growth strategy is to earn repeat business from established accounts rather than to expand into product lines we cannot support to the same standard.
At a glance
| Company Type | Medical sales representative organization and product distributor |
|---|---|
| Territory | Lower 48 United States |
| Product Line | WoundClot® Hemostatic Gauze — Hospital and EMS / First Responder |
| Manufacturer | Core Scientific Creations Ltd. |
| Customers Served | Hospitals, surgery centers, clinics, EMS and fire rescue agencies, law enforcement, military |
| Regulatory Status | Rx Only device; sold to healthcare organizations and licensed practitioners |
02 — Coverage
The lower 48, region by region
Hemovance covers the contiguous United States. Territory assignments are fixed to the account: the representative who conducts the in-service remains the point of contact thereafter.
West
CA, OR, WA, NV, ID, MT, WY, UT, CO
Southwest
AZ, NM, TX, OK
Midwest
ND, SD, NE, KS, MN, IA, MO, WI, IL, MI, IN, OH
Southeast
AR, LA, MS, AL, TN, KY, GA, FL, SC, NC, VA, WV
Northeast
PA, NY, NJ, DE, MD, DC, CT, RI, MA, VT, NH, ME
Outside the distribution area
Alaska, Hawaii and US territories. Enquiries from these locations are referred to the manufacturer.
03 — What we do
Four areas of responsibility
Clinical education
In-service training delivered in the clinical area to the staff who will apply the product: nursing, technicians, residents and prehospital personnel.
Value analysis support
The documentation set required by value analysis committees: regulatory clearance status, biocompatibility summary, published literature and a cost comparison against products currently stocked.
Account support
Reorder management, expiry and stock rotation guidance, refresher education for new staff, and continuity of the assigned representative.
04 — How we work
From first call to standing order
Accounts typically progress through four stages.
Assessment
We review the hemostatic products currently stocked, the departments using them and the associated cost. Where WoundClot® is not appropriate for a given protocol, that is stated.
Evaluation
Evaluation samples are provided to clinical staff together with an in-service, so that the evaluation reflects correct application technique.
Review
The value analysis documentation is assembled and, where requested, presented to the committee. Pricing is set against current expenditure on comparable products.
Supply
Product is entered into the purchasing system, par levels are agreed, and refresher education is scheduled as staffing changes.
05 — How we sell
Commitments to every account
Clinical purchasing decisions warrant scrutiny. The following commitments apply to every account Hemovance serves.
- The device is described as cleared. FDA cleared, not approved; indications as written. Where a claim originates from the manufacturer rather than from published evidence, that is stated.
- Competing products are not disparaged. A like-for-like comparison is provided and the clinical conclusion is left to your staff.
- Existing contracts are respected. Where a sole-source agreement is in place, Hemovance identifies the clinical needs that agreement does not address rather than proposing that it be set aside.
- In-service education precedes the first order. A hemostatic dressing applied without instruction will underperform at the bedside; staff training is scheduled before product is stocked.
- Direct access to a named representative. Each account is assigned a single point of contact with a direct line; enquiries are not routed through a general queue.
- Clinical and safety matters are referred to the manufacturer. Suspected adverse events and device complaints are directed to Core Scientific Creations Ltd. and to your institution's risk management process, not handled through sales channels.
06 — Who you will deal with
A single point of contact
Each account is assigned one representative who is responsible for the relationship in full: the product evaluation, the value analysis submission, in-service education and ongoing supply.
Josh Rackley
Hemovance
Primary contact for product enquiries, evaluation samples, in-service scheduling and value analysis documentation across the lower 48.
Relationship with the manufacturer
WoundClot® is designed and manufactured by Core Scientific Creations Ltd. Hemovance is an independent United States distributor. We are responsible for sales, education and supply in our territory; the manufacturer is responsible for the device, its regulatory clearances and its Instructions for Use.
Clinical and safety enquiries
Product enquiries are directed to Hemovance. Suspected adverse events, device complaints and technical questions about the Instructions for Use should be directed to the manufacturer and through your institution's risk management pathway.
Begin with an assessment
Provide details of the hemostatic products currently stocked and the departments concerned. Hemovance will advise whether WoundClot® offers a clinical or economic advantage in your setting.